Navigation Links
Regeneron Announces Presentation at the 2010 Credit Suisse Annual Healthcare Conference
Date:11/2/2010

TARRYTOWN, N.Y., Nov. 2, 2010 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at the 2010 Credit Suisse Annual Healthcare Conference on Wednesday, November 10, 2010.  The presentation is scheduled for 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time).  The session may be accessed through the Company's web site, www.regeneron.com, on the Investor Relations page.  An archived version of the presentation will be available after the live webcast through December 10, 2010.  

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions.  In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in Phase 3 clinical trials for the potential treatment of gout, diseases of the eye (wet age-related macular degeneration and central retinal vein occlusion), and certain cancers.  Additional therapeutic candidates developed from proprietary Regeneron technologies for creating fully human monoclonal antibodies are in earlier stage development programs in rheumatoid arthritis and other inflammatory conditions, pain, cholesterol reduction, allergic and immune conditions and cancer.  Additional information about Regeneron and recent news releases are available on Regeneron's web site at www.regeneron.com. Contact Information:Michael Aberman, M.D.

Peter DworkinInvestor Relations

Corporate Communications914.345.7799

914.345.7800michael.aberman@regeneron.com

peter.dworkin@regeneron.com
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Regeneron Announces Presentation at the 17th Annual NewsMakers in the Biotech Industry Conference
2. Regeneron Announces Exercise of Over-Allotment Option and Closing of Underwritten Offering of Common Stock
3. Regeneron Increases Size of Public Offering of Common Stock
4. Regeneron Pharmaceuticals, Inc. Announces The Sale of 4,500,000 Shares of Common Stock
5. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
6. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
7. Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference
8. Regeneron Announces Presentation at the Deutsche Bank 2009 Biotech Boston Confab
9. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
10. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
11. Regeneron Reports Third Quarter 2009 Financial and Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Apr. 17, 2015 Research and Markets ... of the "Medical Device Outsourcing - Global ... This report analyzes the worldwide markets ... the following Device Categories: Class I, Class II, ... in the report Include - Radiology, Orthopedic, Neurology, ...
(Date:4/17/2015)... , April 17, 2015 ASSESS ... mutation   is a viable alternative to tumour biopsy   ... in all patients with advanced NSCLC   AstraZeneca ... of plasma circulating tumour DNA (ctDNA) testing for epidermal growth ... advanced non-small cell lung cancer (NSCLC) in clinical practice. [ ...
(Date:4/17/2015)... 17, 2015 Research and Markets ( ... "Medical Oxygen Systems - Global Strategic Business Report" ... the worldwide markets for Medical Oxygen Systems in US$ ... Systems, Oxygen Cylinders & Regulators, and Oxygen Conserving Devices. ... Canada , Japan ...
Breaking Medicine Technology:Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 2Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2
... PHILADELPHIA, Nov. 7, 2011 The Children,s Hospital of ... Grand Challenges Explorations, an initiative created by the Bill ... test unorthodox ideas that address persistent health and development ... of Rheumatology at Children,s Hospital and Professor of Pediatrics ...
... efforts on behalf of the public and private healthcare industry ... today, according to a new book , "Health Industry ... J. Hicks and Christina Mazzola Nicols of Ketchum , ... The book, released this fall from Jones & Bartlett ...
Cached Medicine Technology:The Children's Hospital of Philadelphia Receives Grand Challenges Explorations Funding 2The Children's Hospital of Philadelphia Receives Grand Challenges Explorations Funding 3New Book Highlights Opportunities for Healthcare Industry Communications 2New Book Highlights Opportunities for Healthcare Industry Communications 3New Book Highlights Opportunities for Healthcare Industry Communications 4New Book Highlights Opportunities for Healthcare Industry Communications 5
(Date:4/17/2015)... Illinois (PRWEB) April 18, 2015 Heritage ... will begin its Supportive Living Week Celebration on April ... on having a healthy mind, body and soul. , ... in McLeansboro, Illinois, serves older adults of all incomes, ... maintain their independence. , Supportive Living Week is observed ...
(Date:4/17/2015)... California (PRWEB) April 17, 2015 ... Dr. Kevin Sadati of the Gallery of ... Orange County’s top beauty experts. The publication focused ... lift, facial stem cell fat grafting, eyelid surgery, laser ... facial plastic surgery has resulted in thousands ...
(Date:4/17/2015)... 17, 2015 From the day Dr. Todd ... Texas non-profit organization has empowered young people to create meaningful ... bring fresh water and the Gospel to all of ... Between March 17 and 27, students, faculty and staff raised ... with fresh water and the Good News of Jesus. ...
(Date:4/17/2015)... 17, 2015 Enthusiasts of gourmet cuisine and ... April 25, 2015. The event will be held in the ... (201 Monroe Ave NW, Grand Rapids, MI 49503) and will ... Michigan area. Patrons are encouraged to savor the food and ... , This year’s event will feature seven chefs, including:, ...
(Date:4/17/2015)... York, New York (PRWEB) April 17, 2015 ... that allege this class of prescription medications ... a heart attack, stroke or other life-threatening cardiovascular ... underway in U.S. District Court, Northern District of ... by the U.S. Judicial Panel on Multidistrict Litigation ...
Breaking Medicine News(10 mins):Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 3Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 4
... EpiCept Corporation,(Nasdaq and OMX Nordic Exchange: EPCT) ... be presenting at the 2007 BIO InvestorForum on,October ... the Palace Hotel in San,Francisco, California. Mr. Talley ... http://www.newscom.com/cgi-bin/prnh/20020513/NYM112LOGO ) The presentation will be ...
... Healthcare Services, WASHINGTON, Oct. 3 The American ... override,President Bush,s veto of the State Children,s Health Insurance ... bill by a 265-159 margin. This vote margin,is not ... passed the,measure by a 67-29 margin., "Without this ...
... Million Raised to ... Date, CARLSBAD, ... teaming up,with American Airlines this weekend to support Susan G. Komen for the ... the Four Seasons Resort Aviara and the Del Mar Country Club in,Carlsbad, Calif. ...
... 3 VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ), ... treatment of venous reflux disease, today,announced that it presented ... at 10:00 a.m. ET on October 3, 2007, at ... An archive of the VNUS presentation webcast is ...
... Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) announced today ... October 10, 2007, at 11:45 a.m. PDT (2:45,p.m. EDT). ... in San,Francisco. Steve Worland, Ph.D., President and Chief ... of Anadys and an update on,its two development-stage product ...
... Web site from Northwood,Health Systems has won three awards ... effort in partnership with the best,Web designers in West ... Web site technology," Northwood President and Chief,Executive Officer Pete ... more than 1,000 accredited,continuing education courses for health care ...
Cached Medicine News:Health News:EpiCept Corporation to Present at the 2007 BIO InvestorForum 2Health News:EpiCept Corporation to Present at the 2007 BIO InvestorForum 3Health News:American Academy of Child and Adolescent Psychiatry Reacts to S-CHIP Veto 2Health News:American Airlines 13th Annual Celebrity Golf and Tennis Weekend Will Raise Funds to Fight Breast Cancer 2Health News:American Airlines 13th Annual Celebrity Golf and Tennis Weekend Will Raise Funds to Fight Breast Cancer 3Health News:Anadys Pharmaceuticals to Present at BIO InvestorForum 2007 2
Liquichek™ Ethanol/Ammonia Control is a liquid product used to monitor ethanol and ammonia test procedures in the clinical laboratory....
Lyphochek Assayed Chemistry Control requires no special diluent and has good reconstituted stability for enzymes and CO2. It is assayed for most major instruments and methodologies....
Lyphochek Benzo/TCA Control Set B is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and antidepressant drugs....
Lyphochek Endocrine Control is a human based product designed to monitor plasma catecholamine testing procedures by HPLC. The analytes are spiked at critical concentrations to cover the dynamic range...
Medicine Products: